Delivery Order SPE2DB25D3202-SPE2DB25FTBCV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply) with a ceiling value of $2,271.36. This firm fixed-price delivery order, issued on September 8, 2025, is expected to be completed by September 29, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of YONSA 125 mg tablets (120 count) with a ceiling value of $7,181.01 and a completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's broader relationship...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply). This is a firm fixed-price, non-set-aside delivery order issued on November 4, 2025, with an ultimate completion date of November 26, 2025. YONSA is a prescription medication used in oncology treatment, and the order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count units) valued at $2,271.36 under a firm fixed price contract type. This non-competitive delivery order, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120 count) valued at $9,085.44 under a firm fixed-price contract type. The award was made on September 24, 2025, with an ultimate completion date of October 16, 2025, and was competitively awarded with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of YONSA 125 mg tablets (120 count). This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, is to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation and represents a child contract under AmerisourceBergen's larger federal...
- The Defense Logistics Agency awarded a $2,393.67 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of YONSA 125 mg tablets (120-count packaging), with an ultimate completion date of January 26, 2026. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of YONSA 125 mg tablets (120-count units) with a ceiling value of $2,271.36 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of YONSA 125 mg tablets (120-count units) with a ceiling value of $2,271.36. This is a firm fixed-price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $18,170.88 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count units) on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBCVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120 count) on August 12, 2025, with a ceiling value of $2,271.36. This firm fixed-price delivery order is scheduled for completion by September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and active through December 2026. This prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As one of the nation's major pharmaceutical distributors, AmerisourceBergen demonstrates significant capacity to fulfill federal medical procurement requirements through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/12/25 |